Taipei Exchange - Delayed Quote TWD

Yung Zip Chemical Ind. Co., Ltd. (4102.TWO)

Compare
32.30 +1.30 (+4.19%)
At close: 1:30:38 PM GMT+8
Loading Chart for 4102.TWO
DELL
  • Previous Close 31.00
  • Open 31.30
  • Bid 32.30 x --
  • Ask 32.40 x --
  • Day's Range 31.25 - 33.00
  • 52 Week Range 29.35 - 41.85
  • Volume 456,748
  • Avg. Volume 130,400
  • Market Cap (intraday) 1.369B
  • Beta (5Y Monthly) -0.02
  • PE Ratio (TTM) 15.91
  • EPS (TTM) 2.03
  • Earnings Date --
  • Forward Dividend & Yield 0.80 (2.55%)
  • Ex-Dividend Date Jul 4, 2024
  • 1y Target Est --

Yung Zip Chemical Ind. Co., Ltd., a bulk drug manufacturing company, supplies active pharmaceutical ingredients (APIs), API intermediates, and specialty chemicals worldwide. It offers antihypertensive, iron chelator, anti-inflammatory, analgesic, antipyretic, anti-fungal, schizophrenia, anticoagulant, genital herpes outbreak, hypnotic, and sedative products. The company also offers excipients, such as sodium starch glycolate; and custom research and manufacturing services. Yung Zip Chemical Ind. Co., Ltd was founded in 1978 and is based in Taichung, Taiwan.

www.yungzip.com

182

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4102.TWO

View More

Performance Overview: 4102.TWO

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

4102.TWO
3.36%
TSEC CAPITALIZATION WEIGHTED ST
0.77%

1-Year Return

4102.TWO
15.79%
TSEC CAPITALIZATION WEIGHTED ST
31.23%

3-Year Return

4102.TWO
84.67%
TSEC CAPITALIZATION WEIGHTED ST
26.65%

5-Year Return

4102.TWO
115.38%
TSEC CAPITALIZATION WEIGHTED ST
92.24%

Compare To: 4102.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4102.TWO

View More

Valuation Measures

As of 1/9/2025
  • Market Cap

    1.31B

  • Enterprise Value

    1.33B

  • Trailing P/E

    15.27

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.09

  • Price/Book (mrq)

    1.97

  • Enterprise Value/Revenue

    2.11

  • Enterprise Value/EBITDA

    9.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.06%

  • Return on Assets (ttm)

    5.27%

  • Return on Equity (ttm)

    13.22%

  • Revenue (ttm)

    611.34M

  • Net Income Avi to Common (ttm)

    92.05M

  • Diluted EPS (ttm)

    2.03

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    171.3M

  • Total Debt/Equity (mrq)

    17.80%

  • Levered Free Cash Flow (ttm)

    62.66M

Research Analysis: 4102.TWO

View More

People Also Watch